PROTALIX BIOTHERAPEUTICS Aktie

4,93 EUR 2,7083%

Zu Ihrem Onlinebroker

kaufen verkaufen

PROTALIX BIOTHERAPEUTICS Aktienkurs : 08:24 ( 15 Min. verzögert)
4,93 € Letzter Kurs	2,71% Veränderung	4,80 € Vortag	4,93 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
4,93 - 4,93 Tag	5,60 - 3,11 52 Wochen	0 Tag	0 Ø 52 Wochen	4,87 0 Stücke	5,11 0 Stücke

PROTALIX BIOTHERAPEUTICS Akti…

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

10.05.

Protalix BioTherapeutics to Present at Three Upcoming Healthcare Conferences

CARMIEL, Israel, May 10, 2012 (GlobeNewswire via COMTEX) -- Protalix BioTherapeutics, Inc. (nyse-amex:PLX) (tase:PLX), today announced that senior management will present at three upcoming conferences. Protalix is a biopharmaceutical company focused...
08.05.

Drug-making plant blooms

Technology developed by the biotech firm Protalix Biotherapeutics has made it possible to manufacture drugs inside plant cells. It was midnight when an anxious Ari Zimran finally got...

07.05.

Auriga Raises Protalix BioTherapeutics to Buy (PLX)

... “buy” rating in a report issued on Friday. The firm currently has a $9.00 target price on the stock. Shares of Protalix BioTherapeutics traded ...
06.05.

Protalix execs sell shares

Israeli executives of Protalix Biotherapeutics Inc. (AMEX:PLX; TASE: PLX) have benefitted from the US Food and Drug Administration (FDA) approval of the company's treatment for...
04.05.

First Drug from GM Plant Approved

Made by Israeli biotech Protalix Biotherapeutics and licensed in the US by Pfizer, Elelyso is an enzyme replacement therapy for Gaucher disease, a rare genetic disorder...